The renin-angiotensin system and body function
- PMID: 2992406
The renin-angiotensin system and body function
Abstract
Angiotensin II, the biologically active component of the renin-angiotensin system, acts throughout the body to produce an impressive number of cardiovascular, endocrine, metabolic, and behavioral effects. Major actions include elevation of arterial pressure, stimulation of aldosterone secretion, and a variety of effects on the kidneys, brain, and pituitary. Investigation of the role of the renin-angiotensin system in physiological regulation has been greatly facilitated by the availability of specific inhibitors of the formation or actions of angiotensin II, most notably converting-enzyme inhibitors and angiotensin receptor antagonists. Studies with these agents have clearly shown that the renin-angiotensin system plays an important role in the defense of body balance and blood pressure in hypovolemic state, including sodium deficiency and hemorrhage. The inhibitors also lower blood pressure in some forms of hypertension, and converting-enzyme inhibitors are proving to be effective antihypertensive agents.
Similar articles
-
New therapeutic prospects of renin-angiotensin system inhibition.Clin Exp Hypertens A. 1989;11 Suppl 2:463-70. Clin Exp Hypertens A. 1989. PMID: 2691125 Review.
-
The use of saralasin to evaluate the function of the brain renin-angiotensin system.Prog Biochem Pharmacol. 1976;12:117-34. Prog Biochem Pharmacol. 1976. PMID: 1019160
-
Renal mechanisms of angiotensin II-induced hypertension.Semin Nephrol. 2000 Sep;20(5):417-25. Semin Nephrol. 2000. PMID: 11022893 Review.
-
Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.J Hypertens. 2007 Jan;25(1):25-35. doi: 10.1097/HJH.0b013e3280113950. J Hypertens. 2007. PMID: 17143168 Review.
-
New evidence for brain angiotensin and for its role in hypertension.Fed Proc. 1983 Jul;42(10):2667-72. Fed Proc. 1983. PMID: 6305729
Cited by
-
Consequences of fluid loss in patients treated with ACE inhibitors.Postgrad Med J. 1987 May;63(739):385-7. doi: 10.1136/pgmj.63.739.385. Postgrad Med J. 1987. PMID: 2823245 Free PMC article.
-
The prorenin receptor in the cardiovascular system and beyond.Am J Physiol Heart Circ Physiol. 2018 Feb 1;314(2):H139-H145. doi: 10.1152/ajpheart.00373.2017. Epub 2017 Nov 3. Am J Physiol Heart Circ Physiol. 2018. PMID: 29101170 Free PMC article. Review.
-
Management of Hypertension Using Olmesartan Alone or in Combination.Cardiol Ther. 2017 Jun;6(1):13-32. doi: 10.1007/s40119-017-0087-5. Epub 2017 Mar 3. Cardiol Ther. 2017. PMID: 28258390 Free PMC article. Review.
-
Angiotensin converting enzyme inhibitors and moderate hypertension.Drugs. 1990 Sep;40(3):326-45. doi: 10.2165/00003495-199040030-00002. Drugs. 1990. PMID: 2226219 Review.
-
Renin dynamics in adipose tissue: adipose tissue control of local renin concentrations.Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E343-50. doi: 10.1152/ajpendo.90693.2008. Epub 2008 Dec 2. Am J Physiol Endocrinol Metab. 2009. PMID: 19050177 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources